122 related articles for article (PubMed ID: 27819802)
1. Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
Peluso MJ; Valcour V; Phanuphak N; Ananworanich J; Fletcher JL; Chalermchai T; Krebs SJ; Robb ML; Hellmuth J; Gisslén M; Zetterberg H; Spudich S;
AIDS; 2017 Jan; 31(2):247-252. PubMed ID: 27819802
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection.
Hermansson L; Yilmaz A; Axelsson M; Blennow K; Fuchs D; Hagberg L; Lycke J; Zetterberg H; Gisslén M
J Neuroinflammation; 2019 Jan; 16(1):16. PubMed ID: 30678707
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
[TBL] [Abstract][Full Text] [Related]
4. Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.
Peluso MJ; Valcour V; Ananworanich J; Sithinamsuwan P; Chalermchai T; Fletcher JL; Lerdlum S; Chomchey N; Slike B; Sailasuta N; Gisslén M; Zetterberg H; Spudich S;
J Infect Dis; 2015 Dec; 212(11):1759-67. PubMed ID: 25995196
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy.
Kore I; Ananworanich J; Valcour V; Fletcher JL; Chalermchai T; Paul R; Reynolds J; Tipsuk S; Ubolyam S; Rattanamanee S; Jagodzinski L; Kim J; Spudich S;
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):393-9. PubMed ID: 26509933
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.
Sanford R; Ances BM; Meyerhoff DJ; Price RW; Fuchs D; Zetterberg H; Spudich S; Collins DL
Clin Infect Dis; 2018 Nov; 67(11):1697-1704. PubMed ID: 29697762
[TBL] [Abstract][Full Text] [Related]
7. Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.
Ulfhammer G; Edén A; Mellgren Å; Fuchs D; Zetterberg H; Hagberg L; Nilsson S; Yilmaz A; Gisslén M
AIDS; 2018 Sep; 32(15):2171-2178. PubMed ID: 30005007
[TBL] [Abstract][Full Text] [Related]
8. Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Rahimy E; Li FY; Hagberg L; Fuchs D; Robertson K; Meyerhoff DJ; Zetterberg H; Price RW; Gisslén M; Spudich S
J Infect Dis; 2017 Apr; 215(7):1132-1140. PubMed ID: 28368497
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control.
Calcagno A; Simiele M; Alberione MC; Bracchi M; Marinaro L; Ecclesia S; Di Perri G; D'Avolio A; Bonora S
Clin Infect Dis; 2015 Jan; 60(2):311-7. PubMed ID: 25281609
[TBL] [Abstract][Full Text] [Related]
11. Minimal detection of cerebrospinal fluid escape after initiation of antiretroviral therapy in acute HIV-1 infection.
Handoko R; Chan P; Jagodzinski L; Pinyakorn S; Ubolyam S; Phanuphak N; Sacdalan C; Kroon E; Dumrongpisutikul N; Paul R; Valcour V; Ananworanich J; Vasan S; Spudich S;
AIDS; 2021 Apr; 35(5):777-782. PubMed ID: 33306551
[TBL] [Abstract][Full Text] [Related]
12. The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals.
Jong E; Louw S; van Gorp EC; Meijers JC; ten Cate H; Jacobson BF
Thromb Haemost; 2010 Dec; 104(6):1228-34. PubMed ID: 20886182
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.
Peluso MJ; Meyerhoff DJ; Price RW; Peterson J; Lee E; Young AC; Walter R; Fuchs D; Brew BJ; Cinque P; Robertson K; Hagberg L; Zetterberg H; Gisslén M; Spudich S
J Infect Dis; 2013 Jun; 207(11):1703-12. PubMed ID: 23460748
[TBL] [Abstract][Full Text] [Related]
14. CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.
Lescure FX; Moulignier A; Savatovsky J; Amiel C; Carcelain G; Molina JM; Gallien S; Pacanovski J; Pialoux G; Adle-Biassette H; Gray F
Clin Infect Dis; 2013 Jul; 57(1):101-8. PubMed ID: 23515205
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals.
Krebs SJ; Slike BM; Sithinamsuwan P; Allen IE; Chalermchai T; Tipsuk S; Phanuphak N; Jagodzinski L; Kim JH; Ananworanich J; Marovich MA; Valcour VG;
AIDS; 2016 Jun; 30(10):1533-42. PubMed ID: 26990631
[TBL] [Abstract][Full Text] [Related]
16. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.
Chang CC; Dorasamy AA; Gosnell BI; Elliott JH; Spelman T; Omarjee S; Naranbhai V; Coovadia Y; Ndung'u T; Moosa MY; Lewin SR; French MA
AIDS; 2013 Aug; 27(13):2089-99. PubMed ID: 23525034
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
Anderson AM; Lennox JL; Mulligan MM; Loring DW; Zetterberg H; Blennow K; Kessing C; Koneru R; Easley K; Tyor WR
J Neurovirol; 2017 Feb; 23(1):106-112. PubMed ID: 27400930
[TBL] [Abstract][Full Text] [Related]
18. No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
Krut JJ; Price RW; Zetterberg H; Fuchs D; Hagberg L; Yilmaz A; Cinque P; Nilsson S; Gisslén M
Virulence; 2017 Jul; 8(5):599-604. PubMed ID: 27435879
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
Kester MI; Teunissen CE; Sutphen C; Herries EM; Ladenson JH; Xiong C; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
Alzheimers Res Ther; 2015 Sep; 7(1):59. PubMed ID: 26383836
[TBL] [Abstract][Full Text] [Related]
20. Increased cell-free mitochondrial DNA is a marker of ongoing inflammation and better neurocognitive function in virologically suppressed HIV-infected individuals.
Pérez-Santiago J; De Oliveira MF; Var SR; Day TRC; Woods SP; Gianella S; Mehta SR
J Neurovirol; 2017 Apr; 23(2):283-289. PubMed ID: 27921220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
